NEW YORK (360Dx) – Siemens Healthineers today announced its Atellica Solution platform has received CE marking and is now available globally.
The platform, which comprises flexible, scalable, and automation-ready immunoassay and chemistry analyzers, was recently cleared by the US Food and Drug Administration, and is now commercially available in Europe, the US, South America, and Asia.
According to Siemens, Atellica can combine up to 10 components into more than 300 customizable configurations, including linear, L and U shapes. It can process more than 30 different sample container types, including pediatric and tube top sample cups that can be aspirated from the primary tube. Laboratories can also use the same reagents and consumables across different analyzer configurations, allowing them to streamline inventory and "deliver consistent patient results no matter where patients are tested," Siemens said.